The prescription drug leucovorin is getting a label update, but it’s not what that the US Food and Drug Administration suggested during a White House briefing in September, when officials touted the ...
Zacks Investment Research on MSN

Should you continue to hold DGX stock in your portfolio?

Quest Diagnostics DGX is well-poised to grow in the coming quarters owing to its investments in advanced diagnostics to deliver and scale innovative services. The company’s growth strategy includes ...